Development of Local Cytokine Release Syndrome in a Diffuse large B-cell Lymphoma Following Chimeric Antigen Receptor T-cell Therapy, A Case Report and Literature Review.

DOI Web Site 参考文献13件
  • Seki Hideshige
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Tokushige Junji
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Honda Akira
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Maki Hiroaki
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Morita Ken
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
  • Kurokawa Mineo
    Department of Hematology & Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

説明

<p> We present a unique case of cervical edema-type Localized Cytokine Release Syndrome (L-CRS) following CAR T-cell therapy in an 80-year-old patient with diffuse large B-cell lymphoma (DLBCL). Despite tocilizumab’s typical efficacy in managing CRS, the patient’s L-CRS did not respond to tocilizumab but showed improvement with dexamethasone. The study emphasizes the rarity and potential severity of L-CRS, with only six similar cases reported previously. The observed variability in response to different treatments underscores the complexity of CRS manifestations, requiring tailored approaches for optimal management. This case contributes valuable insights into L-CRS, suggesting its potential manifestation independently of apparent cervical lesions and its differential response to tocilizumab and dexamethasone. Continued vigilance and exploration of management strategies are crucial in this evolving field.</p>

収録刊行物

参考文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ